B-acute lymphoblastic leukemia/lymphoblastic lymphoma (Q26798093)

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Prolonged fever of unknown origin and hemophagocytosis evolving into acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B‐lymphoblastic leukemia in the era of tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Mixed Phenotype Acute Leukemia.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Follicular lymphoma transformed to "double-hit" B lymphoblastic lymphoma presenting in the peritoneal fluid

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11)

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Epstein-Barr virus associated hemophagocytic lymphohystiocytosis during maintenance treatment of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Hemophagocytic lymphohistiocytosis associated with precursor B acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Translocation (14; 18) and (8; 22) in three patients with acute leukemia/lymphoma following centrocytic/centroblastic non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Hemophagocytic lymphohistiocytosis during maintenance treatment of precursor B-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Clinical characteristics and genetic analysis of childhood acute lymphoblastic leukemia with hemophagocytic lymphohistiocytosis: a Japanese retrospective study by the Kyushu-Yamaguchi Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

The importance of cytogenetic studies in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Lymphoblastic lymphoma with primary splenic involvement and the classic 14;18 translocation

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Complex and cryptic chromosomal rearrangements involving the MLL gene in acute leukemia: a study of 7 patients and review of the literature

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Chromosomal translocations involving the IGH@ locus in B-cell precursor acute lymphoblastic leukemia: 29 new cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Ikaros in immune receptor signaling, lymphocyte differentiation, and function.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Immunophenotypic analysis of acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Immunophenotypes in adult acute lymphocytic leukemia. Role of flow cytometry in diagnosis and monitoring of disease.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

The MLL recombinome of acute leukemias in 2013.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Expression of CD25 (interleukin-2 receptor α chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssion

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported i

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL).

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Atypical hemophagocytic lymphohistiocytosis following bacterial tonsillitis in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Histiocytosis following T-acute lymphoblastic leukemia: a BFM study.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Molecular analysis of light-chain switch and acute lymphoblastic leukemia transformation in two follicular lymphomas: implications for lymphomagenesis

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Src-family kinases in the development and therapy of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Hematogones in acute leukemia during and after therapy

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Predicting transformation in follicular lymphoma

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Biologic features and treatment outcome of secondary acute lymphoblastic leukemia--a review of 101 cases

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Hemophagocytic lymphohistiocytosis onset during induction therapy for precursor B-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Pathogenesis of follicular lymphoma

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

CD10- pre-B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: results of the German Multicenter Trials for Adult ALL (GMALL)

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRbeta and FIP1L1-PDGFRalpha in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib).

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

How I treat hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: a single institution experience

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Distinct expression patterns of CD123 and CD34 on normal bone marrow B-cell precursors ("hematogones") and B lymphoblastic leukemia blasts

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Acute lymphoblastic leukemia in elderly patients the Philadelphia chromosome may not be a significant adverse prognostic factor

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Precursor B-lymphoblastic transformation of grade I follicle center lymphoma

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Late-onset fatal Epstein-Barr virus-associated hemophagocytic syndrome following cord blood cell transplantation for adult acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

De novoB lymphoblastic leukemia/lymphoma in an adult with t(14;18)(q32;q21) and c-MYCgene rearrangement involving 10p13

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

MYC rearrangement involving a novel non-immunoglobulin chromosomal locus in precursor B-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCPAN7BH5DNYWZB

7 January 2021

Identifiers

DOI

10.1309/AJCPAN7BH5DNYWZB

1 reference

Consolidated OpenCitations Corpus – April 2017

release_j2qwj2vtinbaxharxcaxlesdfa

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j2qwj2vtinbaxharxcaxlesdfa

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

26276770

1 reference

Consolidated OpenCitations Corpus – April 2017